Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia

Abstract

Hematologists who treat childhood ALL patients, and particularly those who provide primary care to adult survivors, should be aware of the potential for long-term GH deficiency and adverse cardiovascular and diabetes risk profiles as a consequence of leukemia treatment.